Heron Therapeutics, Inc.
HRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818033
No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Heron Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 174 | 186 | +12 |
| Shares | 115.3M | 121.9M | +6.66M (+5.8%) |
| Value | $321.6M | $514.2M | +$192.6M (+59.9%) |
New holders (31)
Institutions that held Heron Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (19)
Institutions that held Heron Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| UBS Oconnor LLC | 10,145,000 | $28.3M |
| C WorldWide Group Holding A/S | 1,202,069 | $3.35M |
| Norges Bank | 887,122 | $2.48M |
| Twinbeech Capital LP | 398,673 | $1.11M |
| Federated Hermes, Inc. | 280,100 | $781.0K |
| Engineers Gate Manager LP | 159,476 | $445.0K |
| Bank of Montreal | 56,680 | $192.0K |
| Virtu Financial LLC | 67,900 | $189.0K |
| Mackenzie Financial Corp | 58,257 | $163.0K |
| HSBC Holdings PLC | 44,407 | $122.0K |
| Two Sigma Securities, LLC | 10,685 | $30.0K |
| Bourgeon Capital Management LLC | 3,000 | $8.00K |
| Aspire Private Capital, LLC | 300 | $1.00K |
| First Manhattan Co | 300 | $0 |
| Howe & Rusling Inc | 50 | $0 |
| Toronto Dominion Bank | 9 | $0 |
| Glassman Wealth Services | 35 | $0 |
| Ellevest, Inc. | 79 | $0 |
| CoreCap Advisors, LLC | 117 | $0 |